Literature DB >> 12748098

Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels.

Ana Londoño1, Mauricio Castillo, Diane Armao, Lester Kwock, Kinuko Suzuki.   

Abstract

We present the case of a patient with an MR imaging study showing an ill-defined intra-axial mass in the right insula and frontal lobe. The mass showed high signal intensity on T2-weighted and fluid-attenuated inversion recovery images and an unusual proton MR spectroscopic imaging pattern characterized by the presence of high levels of myo-inositol/glycine, no significant elevation of choline, and mildly reduced N-acetylaspartate. The histopathologic diagnosis was of diffuse astrocytoma with oligodendroglial components (World Health Organization grade II).

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12748098      PMCID： PMC7975769     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  18 in total

1.  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.

Authors:  G Tedeschi; N Lundbom; R Raman; S Bonavita; J H Duyn; J R Alger; G Di Chiro
Journal:  J Neurosurg       Date:  1997-10       Impact factor: 5.115

2.  Role of gemistocytes in astrocytoma progression.

Authors:  K Watanabe; O Tachibana; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Lab Invest       Date:  1997-02       Impact factor: 5.662

3.  Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.

Authors:  Takao Watanabe; Mitsutoshi Nakamura; Johan M Kros; Christoph Burkhard; Yasuhiro Yonekawa; Paul Kleihues; Hiroko Ohgaki
Journal:  Acta Neuropathol       Date:  2001-11-22       Impact factor: 17.088

4.  Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas.

Authors:  T Tamiya; K Kinoshita; Y Ono; K Matsumoto; T Furuta; T Ohmoto
Journal:  Neuroradiology       Date:  2000-05       Impact factor: 2.804

5.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.

Authors:  A Bitsch; H Bruhn; V Vougioukas; A Stringaris; H Lassmann; J Frahm; W Brück
Journal:  AJNR Am J Neuroradiol       Date:  1999-10       Impact factor: 3.825

Review 6.  Current concepts in neuro-oncology: the cell cycle--a review.

Authors:  P B Dirks; J T Rutka
Journal:  Neurosurgery       Date:  1997-05       Impact factor: 4.654

7.  MR spectroscopy of bilateral thalamic gliomas.

Authors:  F Estève; S Grand; C Rubin; D Hoffmann; B Pasquier; D Graveron-Demilly; R Mahdjoub; J F Le Bas
Journal:  AJNR Am J Neuroradiol       Date:  1999-05       Impact factor: 3.825

8.  Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors.

Authors:  W Paulus; C Grothe; M Sensenbrenner; T Janet; I Baur; M Graf; W Roggendorf
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

9.  The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.

Authors:  F M Schabel
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

10.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology.

Authors:  B L Miller; L Chang; R Booth; T Ernst; M Cornford; D Nikas; D McBride; D J Jenden
Journal:  Life Sci       Date:  1996       Impact factor: 5.037
View more
  8 in total

1.  Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Authors:  Radhika Srinivasan; Joanna J Phillips; Scott R Vandenberg; Mei-Yin C Polley; Gabriela Bourne; Alvin Au; Andrea Pirzkall; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-07-20       Impact factor: 12.300

2.  123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.

Authors:  Michail Plotkin; Julia Eisenacher; Harald Bruhn; Reinhard Wurm; Roger Michel; Florian Stockhammer; Annelie Feussner; Oliver Dudeck; Peter Wust; Roland Felix; Holger Amthauer
Journal:  J Neurooncol       Date:  2004-10       Impact factor: 4.130

3.  Hypothalamic hamartomas: Correlation of MR imaging and spectroscopic findings with tumor glial content.

Authors:  D R Amstutz; S W Coons; J F Kerrigan; H L Rekate; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

4.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

5.  Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.

Authors:  Yan Li; Janine M Lupo; Rupa Parvataneni; Kathleen R Lamborn; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

6.  1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours.

Authors:  Elke Hattingen; Heinrich Lanfermann; Johanna Quick; Kea Franz; Friedhelm E Zanella; Ulrich Pilatus
Journal:  MAGMA       Date:  2008-10-01       Impact factor: 2.310

7.  Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?

Authors:  R Hourani; L J Brant; T Rizk; J D Weingart; P B Barker; A Horská
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-30       Impact factor: 3.825

8.  On the acquisition of the water signal during water suppression: High-speed MR spectroscopic imaging with water referencing and concurrent functional MRI.

Authors:  Stefan Posse; Bruno Sa De La Rocque Guimaraes; Troy Hutchins-Delgado; Kishore Vakamudi; Kevin Fotso Tagne; Steen Moeller; Stephen R Dager
Journal:  NMR Biomed       Date:  2020-01-30       Impact factor: 4.044
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.